Operating Expenses - Cytosorbents Corp (NASDAQ:CTSO) - Alpha Spread

Cytosorbents Corp
NASDAQ:CTSO

Watchlist Manager
Cytosorbents Corp Logo
Cytosorbents Corp
NASDAQ:CTSO
Watchlist
Price: 1.42 USD Market Closed
Market Cap: 77.1m USD
Have any thoughts about
Cytosorbents Corp?
Write Note

Cytosorbents Corp
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cytosorbents Corp
Operating Expenses Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Cytosorbents Corp
NASDAQ:CTSO
Operating Expenses
-$48.1m
CAGR 3-Years
-1%
CAGR 5-Years
-9%
CAGR 10-Years
-24%
Becton Dickinson and Co
NYSE:BDX
Operating Expenses
-$6B
CAGR 3-Years
1%
CAGR 5-Years
-2%
CAGR 10-Years
-7%
Boston Scientific Corp
NYSE:BSX
Operating Expenses
-$7.8B
CAGR 3-Years
-9%
CAGR 5-Years
-8%
CAGR 10-Years
-7%
Stryker Corp
NYSE:SYK
Operating Expenses
-$9.1B
CAGR 3-Years
-9%
CAGR 5-Years
-8%
CAGR 10-Years
-9%
Abbott Laboratories
NYSE:ABT
Operating Expenses
-$15.8B
CAGR 3-Years
-2%
CAGR 5-Years
-3%
CAGR 10-Years
-7%
Intuitive Surgical Inc
NASDAQ:ISRG
Operating Expenses
-$3.1B
CAGR 3-Years
-17%
CAGR 5-Years
-15%
CAGR 10-Years
-14%

See Also

What is Cytosorbents Corp's Operating Expenses?
Operating Expenses
-48.1m USD

Based on the financial report for Jun 30, 2024, Cytosorbents Corp's Operating Expenses amounts to -48.1m USD.

What is Cytosorbents Corp's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-24%

Over the last year, the Operating Expenses growth was 4%. The average annual Operating Expenses growth rates for Cytosorbents Corp have been -1% over the past three years , -9% over the past five years , and -24% over the past ten years .

Back to Top